PART 11 ENFORCEMENT EASED IN CLINICAL TRIALS

Executive Briefing Series
A A

Clinical sites using computerized systems in their trials should rely on the standards outlined in the predicate rules, rather than those listed in 21 CFR Part 11, according to a new guidance issued by the FDA.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00